0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell Line Generation Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-32O11355
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell Line Generation Market Research Report 2022
BUY CHAPTERS

Global Cell Line Generation Market Research Report 2024

Code: QYRE-Auto-32O11355
Report
February 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell Line Generation Market Size

The global Cell Line Generation market was valued at US$ 1678.4 million in 2023 and is anticipated to reach US$ 3184.7 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.

Cell Line Generation Market

Cell Line Generation Market

Cell line generation (CLG) in the scope of bioproduction can be defined as a method to isolate a single cell expressing a recombinant protein of interest.
Global key players of cell line generation include Boehringer Ingelheim BioXcellence, Lonza, WuXi Biologics, Thermo Fisher Scientific, etc. Global top five manufacturers hold a share over 39%. In terms of product, knockout cell lines are the largest segment, with a share over 49%. And in terms of application, the largest application is pharmaceutical industry, with a share over 70%.
This report aims to provide a comprehensive presentation of the global market for Cell Line Generation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Line Generation.

Report Scope

The Cell Line Generation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell Line Generation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Line Generation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell Line Generation Market Report

Report Metric Details
Report Name Cell Line Generation Market
Accounted market size in 2023 US$ 1678.4 million
Forecasted market size in 2030 US$ 3184.7 million
CAGR 10.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Knockout Cell Lines
  • Overexpression Cell Lines
  • Inducible Expression Cell Lines
  • Knockdown Cell Lines
  • Knockin Cell Lines
  • Others
Segment by Application
  • Pharmaceutical Industry
  • Biological Industry
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim BioXcellence, Lonza, WuXi Biologics, Thermo Fisher Scientific, Sartorius, Merck, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Porton Biologics, Chempartner Pharmatech, Rentschler Biopharma, ProBioGen, AGC Biologics, OPM Biosciences, Charles River Laboratories, Mycenax Biotech, JOINN Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell Line Generation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cell Line Generation Market growing?

Ans: The Cell Line Generation Market witnessing a CAGR of 10.0% during the forecast period 2024-2030.

What is the Cell Line Generation Market size in 2030?

Ans: The Cell Line Generation Market size in 2030 will be US$ 3184.7 million.

What is the market share of major companies in Cell Line Generation Market?

Ans: Global top five manufacturers hold a share over 39%.

What is the Cell Line Generation Market share by type?

Ans: In terms of product, knockout cell lines are the largest segment, with a share over 49%.

What is the Cell Line Generation Market share by application?

Ans: And in terms of application, the largest application is pharmaceutical industry, with a share over 70%.

Who are the main players in the Cell Line Generation Market report?

Ans: The main players in the Cell Line Generation Market are Boehringer Ingelheim BioXcellence, Lonza, WuXi Biologics, Thermo Fisher Scientific, Sartorius, Merck, Catalent, Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Porton Biologics, Chempartner Pharmatech, Rentschler Biopharma, ProBioGen, AGC Biologics, OPM Biosciences, Charles River Laboratories, Mycenax Biotech, JOINN Laboratories

What are the Application segmentation covered in the Cell Line Generation Market report?

Ans: The Applications covered in the Cell Line Generation Market report are Pharmaceutical Industry, Biological Industry

What are the Type segmentation covered in the Cell Line Generation Market report?

Ans: The Types covered in the Cell Line Generation Market report are Knockout Cell Lines, Overexpression Cell Lines, Inducible Expression Cell Lines, Knockdown Cell Lines, Knockin Cell Lines, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Line Generation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Knockout Cell Lines
1.2.3 Overexpression Cell Lines
1.2.4 Inducible Expression Cell Lines
1.2.5 Knockdown Cell Lines
1.2.6 Knockin Cell Lines
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cell Line Generation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industry
1.3.3 Biological Industry
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Line Generation Market Perspective (2019-2030)
2.2 Cell Line Generation Growth Trends by Region
2.2.1 Global Cell Line Generation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell Line Generation Historic Market Size by Region (2019-2024)
2.2.3 Cell Line Generation Forecasted Market Size by Region (2025-2030)
2.3 Cell Line Generation Market Dynamics
2.3.1 Cell Line Generation Industry Trends
2.3.2 Cell Line Generation Market Drivers
2.3.3 Cell Line Generation Market Challenges
2.3.4 Cell Line Generation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Line Generation Players by Revenue
3.1.1 Global Top Cell Line Generation Players by Revenue (2019-2024)
3.1.2 Global Cell Line Generation Revenue Market Share by Players (2019-2024)
3.2 Global Cell Line Generation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Line Generation Revenue
3.4 Global Cell Line Generation Market Concentration Ratio
3.4.1 Global Cell Line Generation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Line Generation Revenue in 2023
3.5 Cell Line Generation Key Players Head office and Area Served
3.6 Key Players Cell Line Generation Product Solution and Service
3.7 Date of Enter into Cell Line Generation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Line Generation Breakdown Data by Type
4.1 Global Cell Line Generation Historic Market Size by Type (2019-2024)
4.2 Global Cell Line Generation Forecasted Market Size by Type (2025-2030)
5 Cell Line Generation Breakdown Data by Application
5.1 Global Cell Line Generation Historic Market Size by Application (2019-2024)
5.2 Global Cell Line Generation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell Line Generation Market Size (2019-2030)
6.2 North America Cell Line Generation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell Line Generation Market Size by Country (2019-2024)
6.4 North America Cell Line Generation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Line Generation Market Size (2019-2030)
7.2 Europe Cell Line Generation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell Line Generation Market Size by Country (2019-2024)
7.4 Europe Cell Line Generation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Line Generation Market Size (2019-2030)
8.2 Asia-Pacific Cell Line Generation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell Line Generation Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell Line Generation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Line Generation Market Size (2019-2030)
9.2 Latin America Cell Line Generation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell Line Generation Market Size by Country (2019-2024)
9.4 Latin America Cell Line Generation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Line Generation Market Size (2019-2030)
10.2 Middle East & Africa Cell Line Generation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell Line Generation Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell Line Generation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim BioXcellence
11.1.1 Boehringer Ingelheim BioXcellence Company Detail
11.1.2 Boehringer Ingelheim BioXcellence Business Overview
11.1.3 Boehringer Ingelheim BioXcellence Cell Line Generation Introduction
11.1.4 Boehringer Ingelheim BioXcellence Revenue in Cell Line Generation Business (2019-2024)
11.1.5 Boehringer Ingelheim BioXcellence Recent Development
11.2 Lonza
11.2.1 Lonza Company Detail
11.2.2 Lonza Business Overview
11.2.3 Lonza Cell Line Generation Introduction
11.2.4 Lonza Revenue in Cell Line Generation Business (2019-2024)
11.2.5 Lonza Recent Development
11.3 WuXi Biologics
11.3.1 WuXi Biologics Company Detail
11.3.2 WuXi Biologics Business Overview
11.3.3 WuXi Biologics Cell Line Generation Introduction
11.3.4 WuXi Biologics Revenue in Cell Line Generation Business (2019-2024)
11.3.5 WuXi Biologics Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Cell Line Generation Introduction
11.4.4 Thermo Fisher Scientific Revenue in Cell Line Generation Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Sartorius
11.5.1 Sartorius Company Detail
11.5.2 Sartorius Business Overview
11.5.3 Sartorius Cell Line Generation Introduction
11.5.4 Sartorius Revenue in Cell Line Generation Business (2019-2024)
11.5.5 Sartorius Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Cell Line Generation Introduction
11.6.4 Merck Revenue in Cell Line Generation Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Catalent
11.7.1 Catalent Company Detail
11.7.2 Catalent Business Overview
11.7.3 Catalent Cell Line Generation Introduction
11.7.4 Catalent Revenue in Cell Line Generation Business (2019-2024)
11.7.5 Catalent Recent Development
11.8 Samsung Biologics
11.8.1 Samsung Biologics Company Detail
11.8.2 Samsung Biologics Business Overview
11.8.3 Samsung Biologics Cell Line Generation Introduction
11.8.4 Samsung Biologics Revenue in Cell Line Generation Business (2019-2024)
11.8.5 Samsung Biologics Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Cell Line Generation Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Line Generation Business (2019-2024)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Porton Biologics
11.10.1 Porton Biologics Company Detail
11.10.2 Porton Biologics Business Overview
11.10.3 Porton Biologics Cell Line Generation Introduction
11.10.4 Porton Biologics Revenue in Cell Line Generation Business (2019-2024)
11.10.5 Porton Biologics Recent Development
11.11 Chempartner Pharmatech
11.11.1 Chempartner Pharmatech Company Detail
11.11.2 Chempartner Pharmatech Business Overview
11.11.3 Chempartner Pharmatech Cell Line Generation Introduction
11.11.4 Chempartner Pharmatech Revenue in Cell Line Generation Business (2019-2024)
11.11.5 Chempartner Pharmatech Recent Development
11.12 Rentschler Biopharma
11.12.1 Rentschler Biopharma Company Detail
11.12.2 Rentschler Biopharma Business Overview
11.12.3 Rentschler Biopharma Cell Line Generation Introduction
11.12.4 Rentschler Biopharma Revenue in Cell Line Generation Business (2019-2024)
11.12.5 Rentschler Biopharma Recent Development
11.13 ProBioGen
11.13.1 ProBioGen Company Detail
11.13.2 ProBioGen Business Overview
11.13.3 ProBioGen Cell Line Generation Introduction
11.13.4 ProBioGen Revenue in Cell Line Generation Business (2019-2024)
11.13.5 ProBioGen Recent Development
11.14 AGC Biologics
11.14.1 AGC Biologics Company Detail
11.14.2 AGC Biologics Business Overview
11.14.3 AGC Biologics Cell Line Generation Introduction
11.14.4 AGC Biologics Revenue in Cell Line Generation Business (2019-2024)
11.14.5 AGC Biologics Recent Development
11.15 OPM Biosciences
11.15.1 OPM Biosciences Company Detail
11.15.2 OPM Biosciences Business Overview
11.15.3 OPM Biosciences Cell Line Generation Introduction
11.15.4 OPM Biosciences Revenue in Cell Line Generation Business (2019-2024)
11.15.5 OPM Biosciences Recent Development
11.16 Charles River Laboratories
11.16.1 Charles River Laboratories Company Detail
11.16.2 Charles River Laboratories Business Overview
11.16.3 Charles River Laboratories Cell Line Generation Introduction
11.16.4 Charles River Laboratories Revenue in Cell Line Generation Business (2019-2024)
11.16.5 Charles River Laboratories Recent Development
11.17 Mycenax Biotech
11.17.1 Mycenax Biotech Company Detail
11.17.2 Mycenax Biotech Business Overview
11.17.3 Mycenax Biotech Cell Line Generation Introduction
11.17.4 Mycenax Biotech Revenue in Cell Line Generation Business (2019-2024)
11.17.5 Mycenax Biotech Recent Development
11.18 JOINN Laboratories
11.18.1 JOINN Laboratories Company Detail
11.18.2 JOINN Laboratories Business Overview
11.18.3 JOINN Laboratories Cell Line Generation Introduction
11.18.4 JOINN Laboratories Revenue in Cell Line Generation Business (2019-2024)
11.18.5 JOINN Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Cell Line Generation Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Knockout Cell Lines
    Table 3. Key Players of Overexpression Cell Lines
    Table 4. Key Players of Inducible Expression Cell Lines
    Table 5. Key Players of Knockdown Cell Lines
    Table 6. Key Players of Knockin Cell Lines
    Table 7. Key Players of Others
    Table 8. Global Cell Line Generation Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Cell Line Generation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Cell Line Generation Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Cell Line Generation Market Share by Region (2019-2024)
    Table 12. Global Cell Line Generation Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Cell Line Generation Market Share by Region (2025-2030)
    Table 14. Cell Line Generation Market Trends
    Table 15. Cell Line Generation Market Drivers
    Table 16. Cell Line Generation Market Challenges
    Table 17. Cell Line Generation Market Restraints
    Table 18. Global Cell Line Generation Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Cell Line Generation Market Share by Players (2019-2024)
    Table 20. Global Top Cell Line Generation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Line Generation as of 2023)
    Table 21. Ranking of Global Top Cell Line Generation Companies by Revenue (US$ Million) in 2023
    Table 22. Global 5 Largest Players Market Share by Cell Line Generation Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Cell Line Generation Product Solution and Service
    Table 25. Date of Enter into Cell Line Generation Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Cell Line Generation Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Cell Line Generation Revenue Market Share by Type (2019-2024)
    Table 29. Global Cell Line Generation Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Cell Line Generation Revenue Market Share by Type (2025-2030)
    Table 31. Global Cell Line Generation Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Cell Line Generation Revenue Market Share by Application (2019-2024)
    Table 33. Global Cell Line Generation Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Cell Line Generation Revenue Market Share by Application (2025-2030)
    Table 35. North America Cell Line Generation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Cell Line Generation Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Cell Line Generation Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Cell Line Generation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Europe Cell Line Generation Market Size by Country (2019-2024) & (US$ Million)
    Table 40. Europe Cell Line Generation Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Asia-Pacific Cell Line Generation Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Asia-Pacific Cell Line Generation Market Size by Region (2019-2024) & (US$ Million)
    Table 43. Asia-Pacific Cell Line Generation Market Size by Region (2025-2030) & (US$ Million)
    Table 44. Latin America Cell Line Generation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Latin America Cell Line Generation Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Latin America Cell Line Generation Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Middle East & Africa Cell Line Generation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 48. Middle East & Africa Cell Line Generation Market Size by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Cell Line Generation Market Size by Country (2025-2030) & (US$ Million)
    Table 50. Boehringer Ingelheim BioXcellence Company Detail
    Table 51. Boehringer Ingelheim BioXcellence Business Overview
    Table 52. Boehringer Ingelheim BioXcellence Cell Line Generation Product
    Table 53. Boehringer Ingelheim BioXcellence Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 54. Boehringer Ingelheim BioXcellence Recent Development
    Table 55. Lonza Company Detail
    Table 56. Lonza Business Overview
    Table 57. Lonza Cell Line Generation Product
    Table 58. Lonza Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 59. Lonza Recent Development
    Table 60. WuXi Biologics Company Detail
    Table 61. WuXi Biologics Business Overview
    Table 62. WuXi Biologics Cell Line Generation Product
    Table 63. WuXi Biologics Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 64. WuXi Biologics Recent Development
    Table 65. Thermo Fisher Scientific Company Detail
    Table 66. Thermo Fisher Scientific Business Overview
    Table 67. Thermo Fisher Scientific Cell Line Generation Product
    Table 68. Thermo Fisher Scientific Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 69. Thermo Fisher Scientific Recent Development
    Table 70. Sartorius Company Detail
    Table 71. Sartorius Business Overview
    Table 72. Sartorius Cell Line Generation Product
    Table 73. Sartorius Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 74. Sartorius Recent Development
    Table 75. Merck Company Detail
    Table 76. Merck Business Overview
    Table 77. Merck Cell Line Generation Product
    Table 78. Merck Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 79. Merck Recent Development
    Table 80. Catalent Company Detail
    Table 81. Catalent Business Overview
    Table 82. Catalent Cell Line Generation Product
    Table 83. Catalent Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 84. Catalent Recent Development
    Table 85. Samsung Biologics Company Detail
    Table 86. Samsung Biologics Business Overview
    Table 87. Samsung Biologics Cell Line Generation Product
    Table 88. Samsung Biologics Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 89. Samsung Biologics Recent Development
    Table 90. FUJIFILM Diosynth Biotechnologies Company Detail
    Table 91. FUJIFILM Diosynth Biotechnologies Business Overview
    Table 92. FUJIFILM Diosynth Biotechnologies Cell Line Generation Product
    Table 93. FUJIFILM Diosynth Biotechnologies Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 94. FUJIFILM Diosynth Biotechnologies Recent Development
    Table 95. Porton Biologics Company Detail
    Table 96. Porton Biologics Business Overview
    Table 97. Porton Biologics Cell Line Generation Product
    Table 98. Porton Biologics Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 99. Porton Biologics Recent Development
    Table 100. Chempartner Pharmatech Company Detail
    Table 101. Chempartner Pharmatech Business Overview
    Table 102. Chempartner Pharmatech Cell Line Generation Product
    Table 103. Chempartner Pharmatech Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 104. Chempartner Pharmatech Recent Development
    Table 105. Rentschler Biopharma Company Detail
    Table 106. Rentschler Biopharma Business Overview
    Table 107. Rentschler Biopharma Cell Line Generation Product
    Table 108. Rentschler Biopharma Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 109. Rentschler Biopharma Recent Development
    Table 110. ProBioGen Company Detail
    Table 111. ProBioGen Business Overview
    Table 112. ProBioGen Cell Line Generation Product
    Table 113. ProBioGen Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 114. ProBioGen Recent Development
    Table 115. AGC Biologics Company Detail
    Table 116. AGC Biologics Business Overview
    Table 117. AGC Biologics Cell Line Generation Product
    Table 118. AGC Biologics Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 119. AGC Biologics Recent Development
    Table 120. OPM Biosciences Company Detail
    Table 121. OPM Biosciences Business Overview
    Table 122. OPM Biosciences Cell Line Generation Product
    Table 123. OPM Biosciences Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 124. OPM Biosciences Recent Development
    Table 125. Charles River Laboratories Company Detail
    Table 126. Charles River Laboratories Business Overview
    Table 127. Charles River Laboratories Cell Line Generation Product
    Table 128. Charles River Laboratories Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 129. Charles River Laboratories Recent Development
    Table 130. Mycenax Biotech Company Detail
    Table 131. Mycenax Biotech Business Overview
    Table 132. Mycenax Biotech Cell Line Generation Product
    Table 133. Mycenax Biotech Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 134. Mycenax Biotech Recent Development
    Table 135. JOINN Laboratories Company Detail
    Table 136. JOINN Laboratories Business Overview
    Table 137. JOINN Laboratories Cell Line Generation Product
    Table 138. JOINN Laboratories Revenue in Cell Line Generation Business (2019-2024) & (US$ Million)
    Table 139. JOINN Laboratories Recent Development
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cell Line Generation Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Cell Line Generation Market Share by Type: 2023 VS 2030
    Figure 3. Knockout Cell Lines Features
    Figure 4. Overexpression Cell Lines Features
    Figure 5. Inducible Expression Cell Lines Features
    Figure 6. Knockdown Cell Lines Features
    Figure 7. Knockin Cell Lines Features
    Figure 8. Others Features
    Figure 9. Global Cell Line Generation Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Cell Line Generation Market Share by Application: 2023 VS 2030
    Figure 11. Pharmaceutical Industry Case Studies
    Figure 12. Biological Industry Case Studies
    Figure 13. Cell Line Generation Report Years Considered
    Figure 14. Global Cell Line Generation Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Cell Line Generation Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Cell Line Generation Market Share by Region: 2023 VS 2030
    Figure 17. Global Cell Line Generation Market Share by Players in 2023
    Figure 18. Global Top Cell Line Generation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Line Generation as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Cell Line Generation Revenue in 2023
    Figure 20. North America Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Cell Line Generation Market Share by Country (2019-2030)
    Figure 22. United States Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Cell Line Generation Market Share by Country (2019-2030)
    Figure 26. Germany Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Cell Line Generation Market Share by Region (2019-2030)
    Figure 34. China Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Cell Line Generation Market Share by Country (2019-2030)
    Figure 42. Mexico Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Cell Line Generation Market Share by Country (2019-2030)
    Figure 46. Turkey Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Cell Line Generation Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Boehringer Ingelheim BioXcellence Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 49. Lonza Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 50. WuXi Biologics Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 52. Sartorius Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 53. Merck Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 54. Catalent Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 55. Samsung Biologics Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 56. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 57. Porton Biologics Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 58. Chempartner Pharmatech Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 59. Rentschler Biopharma Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 60. ProBioGen Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 61. AGC Biologics Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 62. OPM Biosciences Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 63. Charles River Laboratories Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 64. Mycenax Biotech Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 65. JOINN Laboratories Revenue Growth Rate in Cell Line Generation Business (2019-2024)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4O8609
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25I8231
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2M4266
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38E8328
Wed Apr 17 00:00:00 UTC 2024

Add to Cart